BioSpace News Archive

Accelus, today announced the launch of FlareHawk7, a multidirectionally expandable lumbar fusion device that is inserted at an ultra-low profile of 7mm to help minimize neural retraction before expanding in both the cranial-caudal and medial-lateral planes to provide sagittal and coronal correction, foraminal height restoration, and the stability to promote fusion.

Cloud robotics is an emerging field of robotics rooted in cloud computing, cloud storage, and other Internet technologies centered on the benefits of converged infrastructure and shared services.

A radiation-free, minimally invasive, image-guided procedure that targets and kills prostate cancer cells is now available at more imaging centers operated by HALO Diagnostics (HALO Dx), an industry leader in advanced diagnostics for early cancer detection.

The growth of the global surgical robotic systems market is majorly driven by surge in rapid technological advancements, increasing investments in R&D and its extensive application in critical surgeries such as cardiac, orthopedic and neurosurgery.

Technological advancements in novel urinary incontinence devices, surge in geriatric population suffering from urological disorders, and rise in healthcare expenditure in developing countries are expected to boost the growth of the global urinary incontinence devices market.

Increase in ownership of companion animals, surge in animal health expenditure, and demand for pet insurance drive the global veterinary infectious disease diagnostics market.

NanoVibronix, Inc., a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave Portable Ultrasonic Therapeutic Devices, announced that the Company’s Annual Meeting of Stockholders was held virtually and broadcast live at www.virtualshareholdermeeting.com/NAOV2021.

Partner Therapeutics, Inc. announced that Frontiers in Immunology published a systematic review of LEUKINE® titled, “Sargramostim as Cancer Therapy and An Immunomodulator.

Ultragenyx Pharmaceutical Inc. today reported the grant of non-qualified stock options to purchase an aggregate of 14,445 shares of common stock of the company and 4,815 restricted stock units of the company’s common stock to two newly hired non-executive officer employees of the company. The awards w

Zivo Bioscience, Inc. today issues a letter to shareholders from Chief Executive Officer Andrew Dahl.